Companies Plan to Unveil Initial Product Offerings at Supply Side West in Las Vegas, Nevada on October 8, 2014
HOBOKEN, NJ / ACCESSWIRE / October 7, 2014 / Optigenex Inc. (OTC Pink: OPGX) (PINKSHEETS: OPGX), and Hill Pharma have partnered to offer unique, new products to the growing sports nutrition, sports performance and weight management dietary supplement markets. The companies plan to unveil at Supply Side West in Las Vegas, Nevada on October 8, 2014. The new products are built around the Optigenex patented rainforest botanical extract, ac-11(r) and principally feature Hill Pharma's next generation and organic plant based proteins. The scientifically validated therapeutic benefits of ac-11(r) provide enhanced energy, and assist in Natural DNA Repair(tm) and recovery. The addition of pea, rice, hemp and pumpkin seed-based proteins and natural sweeteners offered by Hill Pharma's advanced technology will create broad opportunities for offering differentiated products to the customers of both parties in the U.S. and China.
Optigenex's core technology is based on the ability of ac-11(r) to enhance the natural DNA repair processes in our cells. This process, in turn, demonstrably helps the body's ability to heal and recover from physical stress and trauma. The low molecular weight of the active ingredient, as well as its complete water solubility, enable the body to fully utilize the bioactives (called Carboxy Alkyl Esters, or CAEs(tm) in ac-11(r).
Anthony Worth, Managing Director of Optigenex said, "With over 14 years of research behind ac-11(r), ten US patents and proven market acceptance worldwide, we are certain it is time to address key market opportunities by joining forces with other select technology oriented companies." Mr. Worth added, "After careful research of Hill Pharma's protein products, it became clear to us that that we were looking at a new gold standard whose characteristics include; purified organic certified proteins and an excellent taste profile. From that point onward, the potential synergies between Hill Pharma and Optigenex unfolded quickly."
Hill Pharma's CEO, Charles Dong commented, "Hill Pharma had been searching for a technology to help broaden the company's scope of product offerings. In particular, we were looking for an exclusive ingredient backed up by science that could be utilized to supply our customers with the 'best of breed' in nutrient combinations. We believe the health and performance enhancing benefits of ac-11(r), combined with our existing, highly effective protein offerings, will provide just such an opportunity to allow us to offer an array of attractive, highly effective products that consumers will embrace enthusiastically."
About Optigenex Inc.:
Optigenex is a formulator, distributor and provider of proprietary, next generation dietary supplements, skin care products and bulk ingredient featuring ac-11(r) as its core platform technology. AC-11(r) (formerly known as C-MED-100(r)) is a patented, bioactive and water soluble ingredient derived from Uncaria tomentosa, a medicinal herb found in the rain forests of Peru and Brazil.
For more information please visit: http://www.optigenex.com/ and http://www.ac11.com/
About Hill Pharma:
Hill Pharma is a global leader in the dietary supplement and nutritional products industry, producing dietary ingredients and sweeteners from natural sources (plants, nuts and seeds), as well as extracts of botanicals. The company is known in the industry as a premier supplier of customized natural proteins for use in leading edge dietary supplements, sports nutrition products, foods and beverages.
For more information, please visit our website: http://www.hillpharma.com/.
The statements contained in this press release have not been evaluated by the Food and Drug Administration. The Products or ingredients mentioned herein are not intended to diagnose, treat, cure or prevent any disease.
CONTACT:
Dan Zwiren
[email protected]
SOURCE: Optigenex Inc.